Alpha Wave Ventures GP, Ltd sold APMD

August 3, 2026 · Form 4 insider transaction

Alpha Wave Ventures GP, Ltd sold an undisclosed number of shares of Apnimed, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
N/A
Price
$0.00
Total value
N/A
Role
SecurityConvertible Notes
Transaction codeC: Conversion of a derivative
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Includes $1,779,726 of accrued and unpaid interest.; The principal amount of the Convertible Promissory Note (the "Note") (together with accrued interest thereon) automatically converted upon the closing of the IPO into shares of Common Stock. The number of shares reported represents the outstanding principal amount of $20,000,000 plus accrued interest of $1,779,726 as of the IPO closing date, divided by the conversion price of $14.40 per share.; The maturity date of the Note was September 17, 2027, but it automatically converted upon the closing of the IPO prior to the maturity date.; Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the "Reclassification").; Securities held by Alpha Wave Ventures II, LP ("Alpha Wave Ventures"). Alpha Wave Ventures GP, Ltd ("Alpha Wave Ventures GP") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP ("Alpha Wave") and Lunate Holding RSC LTD ("Lunate"). Lunate is majority-owned by Chimera Investment LLC ("Chimera," together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the "Reporting Persons"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate.; For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

View the original Form 4 on SEC EDGAR